Minimal Residual Disease MRD Analysis for TALL Test
Understanding the Importance of MRD Analysis
The Minimal Residual Disease (MRD) Analysis for TALL Test is a specialized diagnostic procedure designed to detect tiny levels of leukemia cells that may remain in the body after treatment. This test is vital for patients diagnosed with T-cell Acute Lymphoblastic Leukemia (TALL) as it helps in assessing the effectiveness of therapy and in making informed decisions regarding ongoing treatment.
What Does the Test Measure?
This test employs advanced flow cytometry techniques to measure specific cell surface markers on blood and bone marrow samples. It detects the presence of residual leukemia cells by identifying specific markers such as CD3, CD4, CD5, CD7, CD8, and others. The precision of this analysis allows healthcare providers to monitor remission status and adjust treatment plans accordingly.
Who Should Consider This Test?
Patients diagnosed with T-cell Acute Lymphoblastic Leukemia (TALL) should consider undergoing the MRD Analysis. It is especially recommended for:
- Individuals in remission who need monitoring for potential relapse.
- Patients undergoing treatment to evaluate the effectiveness of their therapy.
- Those with a history of leukemia and specific risk factors for relapse.
Symptoms may include fatigue, recurrent infections, and unexplained bruising, which should prompt consultation with a healthcare provider.
Benefits of Taking the Test
The MRD Analysis provides several significant benefits, including:
- Early detection of relapse, allowing for timely intervention.
- Informed decision-making regarding treatment adjustments.
- Improved patient outcomes through personalized treatment strategies.
- Increased confidence for both patients and healthcare providers in managing leukemia.
Understanding Your Results
Results from the MRD Analysis will indicate the presence or absence of residual leukemia cells. A lower MRD level is often associated with a better prognosis. Your healthcare provider will guide you through interpreting your results and discussing the next steps in your treatment plan.
Test Name and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Minimal Residual Disease MRD Analysis for TALL Test | 36,000 KSh | 50,000 KSh |
Sample Collection and Instructions
The sample required for this test includes:
- 3 mL (1 mL min.) of first pull Bone Marrow aspirate in 1 Green Top (Sodium Heparin) tube.
- 4 mL (3 mL min.) of whole blood in 1 Green Top (Sodium Heparin) tube.
Samples should be shipped immediately at 18-22°C and must not be refrigerated or frozen. It is mandatory to provide the date and time of sampling, previous immunophenotype report, and clinical history at the time of registration.
Branches Across Kenya
We have branches in all major cities across Kenya and offer home sample collection services for your convenience. To book the Minimal Residual Disease MRD Analysis for TALL Test, please call or WhatsApp us at +254711564616.
